Society partnered with Alzheimer's Society to appoint new Trustees

We are thrilled to announce our collaboration with Alzheimer's Society in the appointment of two new Chairs of Committees and additional Trustees, bringing valuable Health and Social Care expertise to their esteemed Board.

Dementia is arguably the biggest health and social care challenge of our time. An estimated 900,000 people are now living with it in the UK alone, and our existing systems and funding settlements are demonstrably failing to cope. In the face of this growing crisis, Alzheimer’s Society provides a crucial rallying point for optimism about the future.  The commitment to finding individuals with personal connections to the cause, coupled with expertise in finance, audit, or health and social care, highlights the strategic and thoughtful approach.

We secured Phil Andrew for Chair of the Finance and Performance Committee, Anthony Lobo for Chair of the Assurance, Audit and Risk Committee. We also secured Dr Malte Gerhold, for a Trustee role and undergoing clearance for a fourth Trustee. 

Phil Andrew is Group Chief Executive at Orbit, one of the UK’s foremost housing groups. Phil has more 30 years’ experience in leadership positions across the for-profit, governmental contracting and not-for-profit environments. The last 15 years specialising in commercially minded organisations that are driven by social purpose. Phil is delighted at being appointed Chair of the Finance and Performance Committee. 

Anthony Lobo is currently a Board member at KPMG in the UK, where he chairs the Audit Committee and is a member of the Risk Committee and Audit Board. He has been partner at KPMG for more than 16 years specialising in mergers and acquisitions across a variety of sectors, and acting as a global lead partner for one of the firms largest clients over the past 6 years. He has lived and worked in Africa, Asia and Europe during his career and has a wealth of experience in understanding and managing complex businesses. Anthony has been appointed as the new Chair of the Assurance, Risk and Audit Committee shared “I am delighted to be joining the Alzheimer’s Society as a Trustee. It is privilege to be given the opportunity to contribute to such a well-respected and important charity at a time when it is playing an increasingly key role. I have really appreciated how Simon, Usma and Alyce at the Society have each personally supported me through the process from first interaction to appointment. They understood the Alzheimer’s Society’s requirements and where I was in professionally in my journey.”

Dr Malte Gerhold is currently Director of Innovation and Improvement at the Health Foundation, a charitable foundation with the mission to improve health and health care in the UK. He is also a Director of THIS Labs, a start-up that uses large-scale, online collaborative approaches to enable successful improvement and innovation in health and care. Dr Malte Gerhold, newly appointed Trustee shared “I’m so delighted to be joining the Alzheimer’s Society as a trustee. My father has been living with dementia for a decade, with my mother as his sole carer, and so the ambition and mission of the Alzheimer’s Society couldn’t be closer to my heart". Dr Malte Gerhold has held senior leadership roles in the public, private and third sector in health and social care, in the UK and abroad. 

The appointments of Phil Andrew, Anthony Lobo, and Malte Gerhold to key roles within the organisation, including chairing committees and serving as trustees, are commendable steps toward strengthening Alzheimer's Society's leadership. These individuals bring valuable skills and a genuine passion for making a positive impact in the field of dementia care and research. The collaborative and supportive approach described in the statements reflects a promising foundation for future endeavours in the fight against this cruel disease.

Congratulations to the Alzheimer's Society on these significant appointments, and best wishes to the new trustees as they contribute to the ongoing efforts to address the challenges posed by dementia.